Midodrine Treatment for Orthostatic Hypotension

Side Effects and Precautions

• Midodrine should be used cautiously in patients with congestive heart failure and in those using other negative chronotropic agents such as beta-blockers, digoxin, and non-dihydropyridine calcium channel blockers, as recommended by the American Journal of Kidney Diseases 1
• Concomitant use with other alpha-adrenergic agents should be avoided as this may aggravate supine hypertension, according to the American Journal of Kidney Diseases 1
• Midodrine can antagonize the actions of alpha-adrenergic blockers (such as terazosin, prazosin, and doxazosin) and could result in urinary retention, as noted by the American Journal of Kidney Diseases 1

Special Populations

• In hemodialysis patients, midodrine is effectively cleared by hemodialysis with its half-life reduced to 1.4 hours, as reported by the American Journal of Kidney Diseases 1
• For dialysis patients, a single dose of 5 mg administered 30 minutes before dialysis has been shown to improve intradialytic and postdialytic blood pressure, according to the American Journal of Kidney Diseases 1
• Midodrine has minimal cardiac and central nervous system effects due to its specificity for peripheral alpha-receptors and poor penetration across the blood-brain barrier, as stated by the American Journal of Kidney Diseases 1

Treatment Approach

• For patients with resistant orthostatic hypotension, combination approaches may be necessary, such as midodrine with other modalities, as suggested by the American Journal of Kidney Diseases 1

Midodrine Dosing for Orthostatic Hypotension

Dosing Schedule and Administration

• Initial dosing should begin with 10 mg three times daily, taken at approximately 4-hour intervals during daytime hours when the patient needs to be upright and active, as recommended by the American Diabetes Association 2
• Dosing should be individually tailored based on patient response and tolerability, according to the American Diabetes Association 2

Important Considerations

• Midodrine is the only medication approved by the FDA for the treatment of symptomatic orthostatic hypotension, as stated by the American Diabetes Association 2
• Non-pharmacological measures should be tried first, including increased fluid and salt intake, physical counter-maneuvers, and compression garments, as recommended by the American Diabetes Association and the European Society of Cardiology 2, 3
• The therapeutic goal is to minimize postural symptoms rather than to restore normotension, as recommended by the American Diabetes Association 4

Side Effects

• Piloerection (goosebumps) is a common side effect of midodrine, as reported by the American Diabetes Association 2

Management of Orthostatic Hypotension with Midodrine

Non-Pharmacological Interventions

• Increase oral fluid intake to at least 2-2.5 liters daily, unless contraindicated by heart failure status, as recommended by the American Heart Association, to help manage orthostatic hypotension 5
• Consider increased salt intake, unless contraindicated by CHF severity, to help manage orthostatic hypotension, as recommended by the American Heart Association 5
• Implement compression garments, which have Level IIa evidence for benefit in managing orthostatic hypotension, as recommended by the American Heart Association 5
• Teach physical counter-pressure maneuvers, which have Level IIa evidence for benefit in managing orthostatic hypotension, as recommended by the American Heart Association 5

Pharmacological Interventions

• The American Diabetes Association guidelines support midodrine as Level A evidence for symptomatic orthostatic hypotension in diabetic autonomic neuropathy, with significant BP increases at 5 mg doses in clinical trials 6
• The ACC/AHA/HRS guidelines support midodrine as Level IIa (reasonable) for neurogenic orthostatic hypotension, but emphasize that the therapeutic goal is minimizing postural symptoms, not restoring normotension 5

Midodrine Treatment for Orthostatic Hypotension

Introduction to Midodrine

• Midodrine is FDA-approved and represents the only medication with this specific indication for symptomatic orthostatic hypotension, with the therapeutic goal being to minimize postural symptoms rather than restore normotension 7

Non-Pharmacological Measures

• Non-pharmacological measures should be implemented first or concurrently with midodrine, including increased fluid intake, increased salt intake, compression garments, and physical counter-pressure maneuvers 7

Midodrine Dosage for Orthostatic Hypotension

Therapeutic Goals and Non-Pharmacological Measures

• The American Diabetes Association recommends increasing fluid intake to 2-2.5 liters daily, unless contraindicated by heart failure, to help manage orthostatic hypotension 8
• The American Diabetes Association suggests increasing salt intake, unless contraindicated, to help manage orthostatic hypotension 8
• The American Diabetes Association recommends using compression garments over legs and abdomen to help manage orthostatic hypotension 8
• The American Diabetes Association recommends teaching physical counter-pressure maneuvers, such as leg-crossing, squatting, and muscle tensing, to help manage orthostatic hypotension 8

Side Effects and Monitoring

• The therapeutic goal is to minimize postural symptoms, not to restore normotension, and midodrine should only be continued in patients who demonstrate symptomatic improvement during initial treatment, with a strength of evidence supported by the Diabetes/Metabolism Research and Reviews 8
• Urinary retention or urgency is a common side effect, occurring in 4% of patients, and should be monitored regularly 8
• Bradycardia and gastrointestinal symptoms are also common side effects, and should be monitored regularly 8

Midodrine Safety Range for Orthostatic Hypotension

Therapeutic Goals and Monitoring

• The therapeutic goal of midodrine treatment is to minimize postural symptoms rather than restore normotension, and it should be continued only in patients who demonstrate symptomatic improvement during initial treatment, as recommended by the American Diabetes Association, based on evidence from Diabetes/Metabolism Research and Reviews 9

Adverse Effects and Drug Interactions

• Bradycardia and gastrointestinal symptoms may occur in patients taking midodrine at the standard 10 mg three times daily dosing, according to research published in Diabetes/Metabolism Research and Reviews 9

Blood Pressure Parameters for Midodrine Administration

Pre-Treatment Blood Pressure Assessment

• Orthostatic hypotension is defined as a sustained drop of ≥20 mmHg systolic or ≥10 mmHg diastolic within 3 minutes of standing from supine position, according to the American College of Cardiology and European Heart Journal guidelines 10, 11, 12
• The standing blood pressure should be documented to determine the magnitude of orthostatic drop and associated symptoms, as recommended by the European Heart Journal 13

Target Blood Pressure Response

• No cited facts are available for this section

Critical Monitoring Parameters During Treatment

Supine Hypertension Risk

• No cited facts are available for this section

Special Population Considerations

• No cited facts are available for this section